Durvalumab with chemotherapy for neoadjuvant and adjuvant treatment then alone for adjuvant treatment of resectable gastric or gastro-oesophageal junction adenocarcinoma
Technology appraisal guidance
Reference number: TA1160
Published:
Tools and resources
Tools and resources to help you put the guidance into practice.